Polacheck and Cao awarded ARPA-H grant to develop organ-on-chip and AI models for antibody drug development

The Polacheck Lab and Carter Cao's lab at the Eshleman School of Pharmacy were awarded a gran through the Advanced Research Projects Agency for Health (ARPA-H) through the Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program. The grant will fund the Polacheck Lab to develop high-throughput, patient-specific, immune-competent organ-on-chip models that will inform the development of more accurate pharmokinetic models and toxicity predictions, developed by the Cao Lab. More information can be found on the ARPA-H website, here.